Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime ®) in Rio de Janeiro, Brazil

Oliveira-Neto, Manoel Paes de; Mattos, Marise; Pirmez, Claude; Fernandes, Octavio; Gonçalves-Costa, Sylvio Celso; Souza, Celeste de Freitas Silva de; Grimaldi Junior, Gabriel.
Artículo en Inglés | ARCA | ID: arc-15822

Documentos relacionados

  1. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
  2. [In Vitro Efficacy of the Venome of Black Scorpion (Androctonus crassicauda) on Leishmania tropica Promastigotes].
  3. The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.
  4. Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.
  5. Evaluating Brazilian Agriculturalists' IoT Smart Agriculture Adoption Barriers: Understanding Stakeholder Salience Prior to Launching an Innovation.
  6. The scientific publication of the Memórias do Instituto Oswaldo Cruz (1909-2020): a history of contribution to the biomedical sciences.
  7. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.
  8. Traffic impact studies committed to sustainability: The case of Rio de Janeiro.
  9. Revisiting the Phlebotominae subfamily records in Bahia, Brazil.
  10. Long-term follow-up of a case of feline leishmaniosis treated with a combination of allopurinol and meglumine antimoniate.